Incyte Corporation
INCY
$99.13
-$1.19-1.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.27B | 1.51B | 1.37B | 1.22B | 1.05B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.27B | 1.51B | 1.37B | 1.22B | 1.05B |
| Cost of Revenue | 620.43M | 732.55M | 605.59M | 573.68M | 510.47M |
| Gross Profit | 652.25M | 774.29M | 760.40M | 641.85M | 542.43M |
| SG&A Expenses | 327.06M | 388.97M | 328.29M | 330.26M | 324.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 947.49M | 1.12B | 933.87M | 903.94M | 835.44M |
| Operating Income | 325.19M | 385.32M | 432.11M | 311.59M | 217.46M |
| Income Before Tax | 343.60M | 389.94M | 482.31M | 558.01M | 234.19M |
| Income Tax Expenses | 40.27M | 90.66M | 58.14M | 153.01M | 75.99M |
| Earnings from Continuing Operations | 303.33M | 299.28M | 424.17M | 405.00M | 158.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 303.33M | 299.28M | 424.17M | 405.00M | 158.20M |
| EBIT | 325.19M | 385.32M | 432.11M | 311.59M | 217.46M |
| EBITDA | 348.99M | 409.31M | 456.13M | 334.51M | 239.83M |
| EPS Basic | 1.52 | 1.52 | 2.17 | 2.09 | 0.82 |
| Normalized Basic EPS | 1.13 | 1.33 | 1.47 | 1.10 | 0.80 |
| EPS Diluted | 1.47 | 1.46 | 2.11 | 2.04 | 0.80 |
| Normalized Diluted EPS | 1.09 | 1.28 | 1.43 | 1.08 | 0.78 |
| Average Basic Shares Outstanding | 199.34M | 197.44M | 195.67M | 194.00M | 193.71M |
| Average Diluted Shares Outstanding | 206.83M | 204.77M | 201.43M | 198.74M | 198.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |